JP2011501958A - ブタＤＣ−ＳＩＧＮ、ＩＣＡＭ−３およびＬＳＥＣｔｉｎならびにそれらの使用 - Google Patents
ブタＤＣ−ＳＩＧＮ、ＩＣＡＭ−３およびＬＳＥＣｔｉｎならびにそれらの使用 Download PDFInfo
- Publication number
- JP2011501958A JP2011501958A JP2010532042A JP2010532042A JP2011501958A JP 2011501958 A JP2011501958 A JP 2011501958A JP 2010532042 A JP2010532042 A JP 2010532042A JP 2010532042 A JP2010532042 A JP 2010532042A JP 2011501958 A JP2011501958 A JP 2011501958A
- Authority
- JP
- Japan
- Prior art keywords
- virus
- sign
- cells
- porcine
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010037897 DC-specific ICAM-3 grabbing nonintegrin Proteins 0.000 title claims abstract description 99
- 101000766915 Homo sapiens C-type lectin domain family 4 member G Proteins 0.000 title abstract description 152
- 108010064600 Intercellular Adhesion Molecule-3 Proteins 0.000 title abstract description 103
- 102100028666 C-type lectin domain family 4 member G Human genes 0.000 title abstract description 101
- 102100037871 Intercellular adhesion molecule 3 Human genes 0.000 title abstract description 90
- 210000004027 cell Anatomy 0.000 claims abstract description 445
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 267
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 142
- 238000000034 method Methods 0.000 claims abstract description 107
- 239000002299 complementary DNA Substances 0.000 claims abstract description 98
- 241000700605 Viruses Species 0.000 claims abstract description 97
- 241000282414 Homo sapiens Species 0.000 claims abstract description 86
- 210000004443 dendritic cell Anatomy 0.000 claims abstract description 86
- 210000001616 monocyte Anatomy 0.000 claims abstract description 73
- 239000002773 nucleotide Substances 0.000 claims abstract description 64
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 64
- 238000010367 cloning Methods 0.000 claims abstract description 37
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 29
- 230000000295 complement effect Effects 0.000 claims abstract description 26
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 26
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 26
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 12
- 230000001902 propagating effect Effects 0.000 claims abstract description 5
- 241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 claims description 109
- 230000014509 gene expression Effects 0.000 claims description 103
- 239000000047 product Substances 0.000 claims description 54
- 210000005220 cytoplasmic tail Anatomy 0.000 claims description 46
- 208000015181 infectious disease Diseases 0.000 claims description 40
- 239000000427 antigen Substances 0.000 claims description 39
- 108091007433 antigens Proteins 0.000 claims description 39
- 102000036639 antigens Human genes 0.000 claims description 39
- 239000013598 vector Substances 0.000 claims description 36
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 33
- 239000012634 fragment Substances 0.000 claims description 31
- 210000002540 macrophage Anatomy 0.000 claims description 30
- 239000003446 ligand Substances 0.000 claims description 29
- 238000003757 reverse transcription PCR Methods 0.000 claims description 28
- 241001465754 Metazoa Species 0.000 claims description 27
- 241000282898 Sus scrofa Species 0.000 claims description 27
- 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 claims description 25
- 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 claims description 25
- 150000001720 carbohydrates Chemical class 0.000 claims description 23
- 108020001507 fusion proteins Proteins 0.000 claims description 23
- 102000037865 fusion proteins Human genes 0.000 claims description 23
- 241000725303 Human immunodeficiency virus Species 0.000 claims description 21
- 241000288906 Primates Species 0.000 claims description 21
- 241000315672 SARS coronavirus Species 0.000 claims description 21
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 21
- 238000012163 sequencing technique Methods 0.000 claims description 20
- 230000002458 infectious effect Effects 0.000 claims description 17
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims description 15
- 230000003321 amplification Effects 0.000 claims description 15
- 239000008280 blood Substances 0.000 claims description 15
- 239000001963 growth medium Substances 0.000 claims description 15
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 15
- 241001115402 Ebolavirus Species 0.000 claims description 14
- 210000004369 blood Anatomy 0.000 claims description 14
- 210000004698 lymphocyte Anatomy 0.000 claims description 14
- 229920001542 oligosaccharide Polymers 0.000 claims description 14
- 238000001890 transfection Methods 0.000 claims description 13
- 102100021992 CD209 antigen Human genes 0.000 claims description 12
- 241000711549 Hepacivirus C Species 0.000 claims description 12
- 241000526636 Nipah henipavirus Species 0.000 claims description 12
- 241000713311 Simian immunodeficiency virus Species 0.000 claims description 12
- 230000003612 virological effect Effects 0.000 claims description 12
- 230000036039 immunity Effects 0.000 claims description 11
- 150000002482 oligosaccharides Chemical class 0.000 claims description 11
- 241000725619 Dengue virus Species 0.000 claims description 10
- 241001115401 Marburgvirus Species 0.000 claims description 10
- 210000002845 virion Anatomy 0.000 claims description 10
- 241000701024 Human betaherpesvirus 5 Species 0.000 claims description 9
- 210000001185 bone marrow Anatomy 0.000 claims description 9
- 230000000120 cytopathologic effect Effects 0.000 claims description 9
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 8
- 241000710777 Classical swine fever virus Species 0.000 claims description 8
- 241000710803 Equine arteritis virus Species 0.000 claims description 8
- 208000005577 Gastroenteritis Diseases 0.000 claims description 8
- 241000710842 Japanese encephalitis virus Species 0.000 claims description 8
- 241001135549 Porcine epidemic diarrhea virus Species 0.000 claims description 8
- 241000156302 Porcine hemagglutinating encephalomyelitis virus Species 0.000 claims description 8
- 241000711493 Porcine respiratory coronavirus Species 0.000 claims description 8
- 241000710960 Sindbis virus Species 0.000 claims description 8
- 241000725681 Swine influenza virus Species 0.000 claims description 8
- 241000710886 West Nile virus Species 0.000 claims description 8
- 230000003834 intracellular effect Effects 0.000 claims description 8
- 210000000952 spleen Anatomy 0.000 claims description 8
- 241000710780 Bovine viral diarrhea virus 1 Species 0.000 claims description 7
- 241000710945 Eastern equine encephalitis virus Species 0.000 claims description 7
- 241000725579 Feline coronavirus Species 0.000 claims description 7
- 241000724675 Hepatitis E virus Species 0.000 claims description 7
- 241000712431 Influenza A virus Species 0.000 claims description 7
- 241000713196 Influenza B virus Species 0.000 claims description 7
- 241000713297 Influenza C virus Species 0.000 claims description 7
- 241000881705 Porcine endogenous retrovirus Species 0.000 claims description 7
- 241000711798 Rabies lyssavirus Species 0.000 claims description 7
- 241000700584 Simplexvirus Species 0.000 claims description 7
- 241000701093 Suid alphaherpesvirus 1 Species 0.000 claims description 7
- 241001485053 Suid betaherpesvirus 2 Species 0.000 claims description 7
- 241000700565 Swinepox virus Species 0.000 claims description 7
- 241000711975 Vesicular stomatitis virus Species 0.000 claims description 7
- 108091036078 conserved sequence Proteins 0.000 claims description 7
- 230000007812 deficiency Effects 0.000 claims description 7
- 210000004408 hybridoma Anatomy 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 244000309711 non-enveloped viruses Species 0.000 claims description 7
- 241001673669 Porcine circovirus 2 Species 0.000 claims description 6
- 238000010899 nucleation Methods 0.000 claims description 5
- 239000013603 viral vector Substances 0.000 claims description 5
- 101710156618 Peptide deformylase 1 Proteins 0.000 claims description 4
- 239000007795 chemical reaction product Substances 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 4
- 230000002934 lysing effect Effects 0.000 claims description 3
- 235000016709 nutrition Nutrition 0.000 claims description 3
- 210000005259 peripheral blood Anatomy 0.000 claims description 2
- 239000011886 peripheral blood Substances 0.000 claims description 2
- 101000897416 Homo sapiens CD209 antigen Proteins 0.000 claims 10
- 241000282324 Felis Species 0.000 claims 6
- 241000893570 Hendra henipavirus Species 0.000 claims 6
- 102100034343 Integrase Human genes 0.000 claims 3
- 239000013600 plasmid vector Substances 0.000 claims 2
- 210000003527 eukaryotic cell Anatomy 0.000 claims 1
- 210000001236 prokaryotic cell Anatomy 0.000 claims 1
- 108010029485 Protein Isoforms Proteins 0.000 abstract description 49
- 102000001708 Protein Isoforms Human genes 0.000 abstract description 49
- 238000012512 characterization method Methods 0.000 abstract description 21
- 230000012743 protein tagging Effects 0.000 abstract description 3
- 230000001976 improved effect Effects 0.000 abstract description 2
- 235000018102 proteins Nutrition 0.000 description 112
- 239000013615 primer Substances 0.000 description 78
- 108700024394 Exon Proteins 0.000 description 69
- 230000027455 binding Effects 0.000 description 65
- 101000749311 Homo sapiens C-type lectin domain family 4 member M Proteins 0.000 description 58
- 102100040843 C-type lectin domain family 4 member M Human genes 0.000 description 52
- 108020004999 messenger RNA Proteins 0.000 description 46
- 241000283690 Bos taurus Species 0.000 description 39
- 102000056354 human CLEC4G Human genes 0.000 description 35
- 102000005962 receptors Human genes 0.000 description 35
- 108020003175 receptors Proteins 0.000 description 35
- 230000003993 interaction Effects 0.000 description 30
- 210000001165 lymph node Anatomy 0.000 description 30
- 241000282887 Suidae Species 0.000 description 28
- 210000004185 liver Anatomy 0.000 description 27
- 102000004196 processed proteins & peptides Human genes 0.000 description 27
- 244000052769 pathogen Species 0.000 description 26
- 102000003930 C-Type Lectins Human genes 0.000 description 25
- 108090000342 C-Type Lectins Proteins 0.000 description 25
- 101000599862 Homo sapiens Intercellular adhesion molecule 3 Proteins 0.000 description 25
- 238000000338 in vitro Methods 0.000 description 25
- 102100037872 Intercellular adhesion molecule 2 Human genes 0.000 description 24
- 241000699666 Mus <mouse, genus> Species 0.000 description 23
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 23
- 239000002953 phosphate buffered saline Substances 0.000 description 23
- 229920001184 polypeptide Polymers 0.000 description 22
- 241000894007 species Species 0.000 description 22
- 210000001519 tissue Anatomy 0.000 description 22
- 108700026244 Open Reading Frames Proteins 0.000 description 21
- 210000005105 peripheral blood lymphocyte Anatomy 0.000 description 21
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 20
- 108020004414 DNA Proteins 0.000 description 20
- 241000283073 Equus caballus Species 0.000 description 19
- 235000014633 carbohydrates Nutrition 0.000 description 19
- 239000002679 microRNA Substances 0.000 description 19
- 238000010186 staining Methods 0.000 description 19
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 18
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 18
- 108091026890 Coding region Proteins 0.000 description 17
- 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 17
- 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 17
- 108020005067 RNA Splice Sites Proteins 0.000 description 17
- 210000001744 T-lymphocyte Anatomy 0.000 description 17
- 238000012217 deletion Methods 0.000 description 17
- 230000037430 deletion Effects 0.000 description 17
- 210000002889 endothelial cell Anatomy 0.000 description 17
- 230000028993 immune response Effects 0.000 description 17
- 239000002523 lectin Substances 0.000 description 17
- 241000282465 Canis Species 0.000 description 16
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 16
- 230000002441 reversible effect Effects 0.000 description 16
- 108020004485 Nonsense Codon Proteins 0.000 description 15
- 108091008109 Pseudogenes Proteins 0.000 description 15
- 102000057361 Pseudogenes Human genes 0.000 description 15
- 230000002788 anti-peptide Effects 0.000 description 15
- 239000011575 calcium Substances 0.000 description 15
- 230000001419 dependent effect Effects 0.000 description 15
- 238000001514 detection method Methods 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 15
- 239000012091 fetal bovine serum Substances 0.000 description 15
- 230000035772 mutation Effects 0.000 description 15
- 102000016289 Cell Adhesion Molecules Human genes 0.000 description 14
- 108010067225 Cell Adhesion Molecules Proteins 0.000 description 14
- 210000001132 alveolar macrophage Anatomy 0.000 description 14
- 150000001413 amino acids Chemical class 0.000 description 14
- 239000000203 mixture Substances 0.000 description 14
- 239000013612 plasmid Substances 0.000 description 14
- 101710148794 Intercellular adhesion molecule 2 Proteins 0.000 description 13
- 230000006870 function Effects 0.000 description 13
- 230000001404 mediated effect Effects 0.000 description 13
- 230000001717 pathogenic effect Effects 0.000 description 13
- 102100034349 Integrase Human genes 0.000 description 12
- 108091092195 Intron Proteins 0.000 description 12
- 108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 description 12
- 235000001014 amino acid Nutrition 0.000 description 12
- 229940024606 amino acid Drugs 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 12
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 12
- 230000037434 nonsense mutation Effects 0.000 description 12
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 11
- 102000003886 Glycoproteins Human genes 0.000 description 11
- 108090000288 Glycoproteins Proteins 0.000 description 11
- 241000282412 Homo Species 0.000 description 11
- 101000599858 Homo sapiens Intercellular adhesion molecule 2 Proteins 0.000 description 11
- 108700011259 MicroRNAs Proteins 0.000 description 11
- 241000282577 Pan troglodytes Species 0.000 description 11
- 230000004927 fusion Effects 0.000 description 11
- 230000008569 process Effects 0.000 description 11
- 229960005486 vaccine Drugs 0.000 description 11
- 101000599861 Bos taurus Intercellular adhesion molecule 3 Proteins 0.000 description 10
- 241000282560 Macaca mulatta Species 0.000 description 10
- 238000012300 Sequence Analysis Methods 0.000 description 10
- 238000003556 assay Methods 0.000 description 10
- 238000010790 dilution Methods 0.000 description 10
- 239000012895 dilution Substances 0.000 description 10
- 238000009826 distribution Methods 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 238000000684 flow cytometry Methods 0.000 description 10
- 238000003364 immunohistochemistry Methods 0.000 description 10
- 230000007246 mechanism Effects 0.000 description 10
- 230000010076 replication Effects 0.000 description 10
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 9
- 241000283707 Capra Species 0.000 description 9
- 241000289427 Didelphidae Species 0.000 description 9
- 239000003242 anti bacterial agent Substances 0.000 description 9
- 229940088710 antibiotic agent Drugs 0.000 description 9
- 230000005540 biological transmission Effects 0.000 description 9
- 229910052791 calcium Inorganic materials 0.000 description 9
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Natural products O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 9
- 239000013067 intermediate product Substances 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 9
- 108091070501 miRNA Proteins 0.000 description 9
- 230000036961 partial effect Effects 0.000 description 9
- 230000037361 pathway Effects 0.000 description 9
- 101000878605 Homo sapiens Low affinity immunoglobulin epsilon Fc receptor Proteins 0.000 description 8
- 102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 description 8
- 108091081024 Start codon Proteins 0.000 description 8
- 101710090322 Truncated surface protein Proteins 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 8
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 8
- 230000002163 immunogen Effects 0.000 description 8
- 210000005228 liver tissue Anatomy 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 230000008488 polyadenylation Effects 0.000 description 8
- 108010038196 saccharide-binding proteins Proteins 0.000 description 8
- 241000282472 Canis lupus familiaris Species 0.000 description 7
- 102000004856 Lectins Human genes 0.000 description 7
- 108090001090 Lectins Proteins 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 7
- 230000004988 N-glycosylation Effects 0.000 description 7
- 241000289371 Ornithorhynchus anatinus Species 0.000 description 7
- 108010076504 Protein Sorting Signals Proteins 0.000 description 7
- 108091005956 Type II transmembrane proteins Proteins 0.000 description 7
- 210000000612 antigen-presenting cell Anatomy 0.000 description 7
- 230000010261 cell growth Effects 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 238000011161 development Methods 0.000 description 7
- 238000001727 in vivo Methods 0.000 description 7
- 210000000265 leukocyte Anatomy 0.000 description 7
- 238000002826 magnetic-activated cell sorting Methods 0.000 description 7
- 239000012528 membrane Substances 0.000 description 7
- 238000013081 phylogenetic analysis Methods 0.000 description 7
- 238000012545 processing Methods 0.000 description 7
- 108020005345 3' Untranslated Regions Proteins 0.000 description 6
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 6
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 6
- 102000012750 Membrane Glycoproteins Human genes 0.000 description 6
- 108010090054 Membrane Glycoproteins Proteins 0.000 description 6
- 238000009004 PCR Kit Methods 0.000 description 6
- 241001494479 Pecora Species 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 239000005090 green fluorescent protein Substances 0.000 description 6
- 238000011534 incubation Methods 0.000 description 6
- -1 mannose glycan Chemical class 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 210000004980 monocyte derived macrophage Anatomy 0.000 description 6
- 108700000180 mouse LSECtin Proteins 0.000 description 6
- 230000003169 placental effect Effects 0.000 description 6
- 210000001541 thymus gland Anatomy 0.000 description 6
- 238000011144 upstream manufacturing Methods 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 102000014914 Carrier Proteins Human genes 0.000 description 5
- 108020004705 Codon Proteins 0.000 description 5
- 102000004127 Cytokines Human genes 0.000 description 5
- 108090000695 Cytokines Proteins 0.000 description 5
- 108091092724 Noncoding DNA Proteins 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 108010083644 Ribonucleases Proteins 0.000 description 5
- 102000006382 Ribonucleases Human genes 0.000 description 5
- 230000004913 activation Effects 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 230000012202 endocytosis Effects 0.000 description 5
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 5
- 239000013604 expression vector Substances 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 230000006698 induction Effects 0.000 description 5
- 238000003780 insertion Methods 0.000 description 5
- 230000037431 insertion Effects 0.000 description 5
- 239000000543 intermediate Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 5
- 102000007863 pattern recognition receptors Human genes 0.000 description 5
- 108010089193 pattern recognition receptors Proteins 0.000 description 5
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 5
- 102100026197 C-type lectin domain family 2 member D Human genes 0.000 description 4
- 108020004635 Complementary DNA Proteins 0.000 description 4
- 241000711573 Coronaviridae Species 0.000 description 4
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 4
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 4
- 241000283086 Equidae Species 0.000 description 4
- 241000713800 Feline immunodeficiency virus Species 0.000 description 4
- 101000912615 Homo sapiens C-type lectin domain family 2 member D Proteins 0.000 description 4
- 239000012097 Lipofectamine 2000 Substances 0.000 description 4
- 229920000057 Mannan Polymers 0.000 description 4
- 108091027974 Mature messenger RNA Proteins 0.000 description 4
- 241001529936 Murinae Species 0.000 description 4
- 101000599857 Mus musculus Intercellular adhesion molecule 1 Proteins 0.000 description 4
- 238000012408 PCR amplification Methods 0.000 description 4
- 238000011530 RNeasy Mini Kit Methods 0.000 description 4
- 241000283984 Rodentia Species 0.000 description 4
- 108010029176 Sialic Acid Binding Ig-like Lectin 1 Proteins 0.000 description 4
- 102100032855 Sialoadhesin Human genes 0.000 description 4
- 230000005867 T cell response Effects 0.000 description 4
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 4
- 108091008324 binding proteins Proteins 0.000 description 4
- 239000013611 chromosomal DNA Substances 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 238000004925 denaturation Methods 0.000 description 4
- 230000036425 denaturation Effects 0.000 description 4
- 210000001198 duodenum Anatomy 0.000 description 4
- 239000003623 enhancer Substances 0.000 description 4
- 230000037433 frameshift Effects 0.000 description 4
- 108091008053 gene clusters Proteins 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 4
- 210000000987 immune system Anatomy 0.000 description 4
- 230000003053 immunization Effects 0.000 description 4
- 238000010166 immunofluorescence Methods 0.000 description 4
- 238000013388 immunohistochemistry analysis Methods 0.000 description 4
- 210000001985 kidney epithelial cell Anatomy 0.000 description 4
- 230000000670 limiting effect Effects 0.000 description 4
- 244000144972 livestock Species 0.000 description 4
- 230000004807 localization Effects 0.000 description 4
- 239000012188 paraffin wax Substances 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 238000000159 protein binding assay Methods 0.000 description 4
- 230000003252 repetitive effect Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 4
- 210000002027 skeletal muscle Anatomy 0.000 description 4
- 230000008685 targeting Effects 0.000 description 4
- 230000002123 temporal effect Effects 0.000 description 4
- 238000004448 titration Methods 0.000 description 4
- 230000032258 transport Effects 0.000 description 4
- 238000001262 western blot Methods 0.000 description 4
- 238000002689 xenotransplantation Methods 0.000 description 4
- 208000030507 AIDS Diseases 0.000 description 3
- 241000282693 Cercopithecidae Species 0.000 description 3
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 229920001917 Ficoll Polymers 0.000 description 3
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 3
- 102000039966 ICAM family Human genes 0.000 description 3
- 108091069108 ICAM family Proteins 0.000 description 3
- 101150040790 ICAM3 gene Proteins 0.000 description 3
- 108060003951 Immunoglobulin Proteins 0.000 description 3
- 102100037874 Intercellular adhesion molecule 4 Human genes 0.000 description 3
- 108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 3
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 3
- 108010052285 Membrane Proteins Proteins 0.000 description 3
- 241001467552 Mycobacterium bovis BCG Species 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 241000282579 Pan Species 0.000 description 3
- 229940096437 Protein S Drugs 0.000 description 3
- 238000002123 RNA extraction Methods 0.000 description 3
- 101710198474 Spike protein Proteins 0.000 description 3
- 102000002689 Toll-like receptor Human genes 0.000 description 3
- 108020000411 Toll-like receptor Proteins 0.000 description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
- 108010003533 Viral Envelope Proteins Proteins 0.000 description 3
- 230000001464 adherent effect Effects 0.000 description 3
- 238000003277 amino acid sequence analysis Methods 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229960002685 biotin Drugs 0.000 description 3
- 239000011616 biotin Substances 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 230000017455 cell-cell adhesion Effects 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 125000000151 cysteine group Chemical class N[C@@H](CS)C(=O)* 0.000 description 3
- 229930182830 galactose Natural products 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 102000050442 human CLEC4M Human genes 0.000 description 3
- 210000003917 human chromosome Anatomy 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 238000002649 immunization Methods 0.000 description 3
- 102000018358 immunoglobulin Human genes 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 210000003292 kidney cell Anatomy 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 210000005229 liver cell Anatomy 0.000 description 3
- 210000005210 lymphoid organ Anatomy 0.000 description 3
- 125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 238000010369 molecular cloning Methods 0.000 description 3
- 210000004877 mucosa Anatomy 0.000 description 3
- 238000002887 multiple sequence alignment Methods 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 238000002703 mutagenesis Methods 0.000 description 3
- 231100000350 mutagenesis Toxicity 0.000 description 3
- 210000000066 myeloid cell Anatomy 0.000 description 3
- 230000008520 organization Effects 0.000 description 3
- 101150078841 pan gene Proteins 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000002062 proliferating effect Effects 0.000 description 3
- 230000000644 propagated effect Effects 0.000 description 3
- 230000000284 resting effect Effects 0.000 description 3
- 238000002864 sequence alignment Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 230000009897 systematic effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 239000003656 tris buffered saline Substances 0.000 description 3
- 239000004474 valine Substances 0.000 description 3
- 230000007501 viral attachment Effects 0.000 description 3
- 241000606748 Actinobacillus pleuropneumoniae Species 0.000 description 2
- 108090001008 Avidin Proteins 0.000 description 2
- 108050009406 C-type lectin-like Proteins 0.000 description 2
- 101710126509 CD209 antigen Proteins 0.000 description 2
- 102000005701 Calcium-Binding Proteins Human genes 0.000 description 2
- 108010045403 Calcium-Binding Proteins Proteins 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 108091035707 Consensus sequence Proteins 0.000 description 2
- 201000011001 Ebola Hemorrhagic Fever Diseases 0.000 description 2
- 241000710188 Encephalomyocarditis virus Species 0.000 description 2
- 108700039887 Essential Genes Proteins 0.000 description 2
- 241000711950 Filoviridae Species 0.000 description 2
- 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- CBOVGULVQSVMPT-CIUDSAMLSA-N Glu-Pro-Asn Chemical group [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O CBOVGULVQSVMPT-CIUDSAMLSA-N 0.000 description 2
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 2
- 208000031886 HIV Infections Diseases 0.000 description 2
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- 229920002971 Heparan sulfate Polymers 0.000 description 2
- 108010073141 Hepatitis C virus glycoprotein E2 Proteins 0.000 description 2
- 101000935040 Homo sapiens Integrin beta-2 Proteins 0.000 description 2
- 101000599852 Homo sapiens Intercellular adhesion molecule 1 Proteins 0.000 description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
- 102100025390 Integrin beta-2 Human genes 0.000 description 2
- 101710148793 Intercellular adhesion molecule 4 Proteins 0.000 description 2
- 102000004388 Interleukin-4 Human genes 0.000 description 2
- 108090000978 Interleukin-4 Proteins 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 102000018697 Membrane Proteins Human genes 0.000 description 2
- 206010027476 Metastases Diseases 0.000 description 2
- 102000018656 Mitogen Receptors Human genes 0.000 description 2
- 108010052006 Mitogen Receptors Proteins 0.000 description 2
- 241000186359 Mycobacterium Species 0.000 description 2
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 2
- OVRNDRQMDRJTHS-RTRLPJTCSA-N N-acetyl-D-glucosamine Chemical group CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-RTRLPJTCSA-N 0.000 description 2
- 239000012124 Opti-MEM Substances 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- 241000723990 Papaya ringspot virus Species 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 description 2
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 101710167605 Spike glycoprotein Proteins 0.000 description 2
- 108010090804 Streptavidin Proteins 0.000 description 2
- 108091036066 Three prime untranslated region Proteins 0.000 description 2
- 108070000030 Viral receptors Proteins 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 229940126575 aminoglycoside Drugs 0.000 description 2
- 238000012197 amplification kit Methods 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 229960000190 bacillus calmette–guérin vaccine Drugs 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 230000021164 cell adhesion Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 230000001086 cytosolic effect Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 150000002016 disaccharides Chemical class 0.000 description 2
- 210000003038 endothelium Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 239000013613 expression plasmid Substances 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 239000012997 ficoll-paque Substances 0.000 description 2
- PGBHMTALBVVCIT-VCIWKGPPSA-N framycetin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO PGBHMTALBVVCIT-VCIWKGPPSA-N 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 239000012737 fresh medium Substances 0.000 description 2
- 230000004547 gene signature Effects 0.000 description 2
- 238000012268 genome sequencing Methods 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000013595 glycosylation Effects 0.000 description 2
- 238000006206 glycosylation reaction Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 230000016784 immunoglobulin production Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000015788 innate immune response Effects 0.000 description 2
- 108010044426 integrins Proteins 0.000 description 2
- 102000006495 integrins Human genes 0.000 description 2
- 229940028885 interleukin-4 Drugs 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 210000001365 lymphatic vessel Anatomy 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 102000027540 membrane-bound PRRs Human genes 0.000 description 2
- 108091008872 membrane-bound PRRs Proteins 0.000 description 2
- 230000009401 metastasis Effects 0.000 description 2
- 108091056360 miR-350 stem-loop Proteins 0.000 description 2
- 108091061985 miR-350-1 stem-loop Proteins 0.000 description 2
- 108091086625 miR-350-2 stem-loop Proteins 0.000 description 2
- 239000011325 microbead Substances 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 239000007758 minimum essential medium Substances 0.000 description 2
- 230000004001 molecular interaction Effects 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 201000000050 myeloid neoplasm Diseases 0.000 description 2
- 229940053050 neomycin sulfate Drugs 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000026731 phosphorylation Effects 0.000 description 2
- 238000006366 phosphorylation reaction Methods 0.000 description 2
- 230000004962 physiological condition Effects 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 108091033319 polynucleotide Proteins 0.000 description 2
- 102000040430 polynucleotide Human genes 0.000 description 2
- 239000002157 polynucleotide Substances 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000011165 process development Methods 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- 230000014891 regulation of alternative nuclear mRNA splicing, via spliceosome Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000003362 replicative effect Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 102000014452 scavenger receptors Human genes 0.000 description 2
- 108010078070 scavenger receptors Proteins 0.000 description 2
- 210000005212 secondary lymphoid organ Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 208000010648 susceptibility to HIV infection Diseases 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000003146 transient transfection Methods 0.000 description 2
- 238000002255 vaccination Methods 0.000 description 2
- 230000005570 vertical transmission Effects 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- ODWNBAWYDSWOAF-UHFFFAOYSA-N 2,4,4-trimethylpentan-2-yloxybenzene Chemical compound CC(C)(C)CC(C)(C)OC1=CC=CC=C1 ODWNBAWYDSWOAF-UHFFFAOYSA-N 0.000 description 1
- WONRDHPFOHAWOG-UHFFFAOYSA-N 2-chloronaphthalen-1-ol Chemical compound C1=CC=C2C(O)=C(Cl)C=CC2=C1 WONRDHPFOHAWOG-UHFFFAOYSA-N 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- 241001292006 Arteriviridae Species 0.000 description 1
- 208000007467 Arterivirus Infections Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 208000032116 Autoimmune Experimental Encephalomyelitis Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 241000606125 Bacteroides Species 0.000 description 1
- 206010057361 Blood brain barrier defect Diseases 0.000 description 1
- 241000588779 Bordetella bronchiseptica Species 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 108091078235 Canis familiaris miR-350 stem-loop Proteins 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 102100024046 Cell adhesion molecule 3 Human genes 0.000 description 1
- 101710197433 Cell adhesion molecule 3 Proteins 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 208000006332 Choriocarcinoma Diseases 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108090000909 Collectins Proteins 0.000 description 1
- 102000004405 Collectins Human genes 0.000 description 1
- 102100032768 Complement receptor type 2 Human genes 0.000 description 1
- 108010060123 Conjugate Vaccines Proteins 0.000 description 1
- 102100031673 Corneodesmosin Human genes 0.000 description 1
- 101710139375 Corneodesmosin Proteins 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- 241001559589 Cullen Species 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 206010012310 Dengue fever Diseases 0.000 description 1
- 241000710829 Dengue virus group Species 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000710781 Flaviviridae Species 0.000 description 1
- 101150034914 GP2a gene Proteins 0.000 description 1
- 101000834253 Gallus gallus Actin, cytoplasmic 1 Proteins 0.000 description 1
- 241000606807 Glaesserella parasuis Species 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 101710114810 Glycoprotein Proteins 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 208000037357 HIV infectious disease Diseases 0.000 description 1
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 241000700586 Herpesviridae Species 0.000 description 1
- 241001272567 Hominoidea Species 0.000 description 1
- 101000941929 Homo sapiens Complement receptor type 2 Proteins 0.000 description 1
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 1
- 101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 description 1
- 101000599868 Homo sapiens Intercellular adhesion molecule 4 Proteins 0.000 description 1
- 101000632467 Homo sapiens Pulmonary surfactant-associated protein D Proteins 0.000 description 1
- 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 description 1
- 102000003839 Human Proteins Human genes 0.000 description 1
- 108090000144 Human Proteins Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 108010042653 IgA receptor Proteins 0.000 description 1
- 108010073816 IgE Receptors Proteins 0.000 description 1
- 102000009438 IgE Receptors Human genes 0.000 description 1
- 108700005091 Immunoglobulin Genes Proteins 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 102100022338 Integrin alpha-M Human genes 0.000 description 1
- 102100022337 Integrin alpha-V Human genes 0.000 description 1
- 102100039919 Intercellular adhesion molecule 5 Human genes 0.000 description 1
- 101710148796 Intercellular adhesion molecule 5 Proteins 0.000 description 1
- 102000002227 Interferon Type I Human genes 0.000 description 1
- 108010014726 Interferon Type I Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 241000282561 Macaca nemestrina Species 0.000 description 1
- 108010068997 Mannose-Binding Lectins Proteins 0.000 description 1
- 102000001698 Mannose-Binding Lectins Human genes 0.000 description 1
- 108010061593 Member 14 Tumor Necrosis Factor Receptors Proteins 0.000 description 1
- 108091030146 MiRBase Proteins 0.000 description 1
- 108091028684 Mir-145 Proteins 0.000 description 1
- 101000761989 Mus musculus CD209 antigen-like protein A Proteins 0.000 description 1
- 101100452013 Mus musculus Icam1 gene Proteins 0.000 description 1
- 101000599865 Mus musculus Intercellular adhesion molecule 4 Proteins 0.000 description 1
- 241000186366 Mycobacterium bovis Species 0.000 description 1
- 241000204045 Mycoplasma hyopneumoniae Species 0.000 description 1
- 241001553014 Myrsine salicina Species 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- SPEFJYZGXZENAF-UHFFFAOYSA-N N-cyclohexyl-1-(2,4-dichlorophenyl)-6-methyl-4H-indeno[1,2-c]pyrazole-3-carboxamide Chemical compound C=1C(C)=CC=C(C2=3)C=1CC=3C(C(=O)NC1CCCCC1)=NN2C1=CC=C(Cl)C=C1Cl SPEFJYZGXZENAF-UHFFFAOYSA-N 0.000 description 1
- 102100023064 Nectin-1 Human genes 0.000 description 1
- 101710043845 Nectin-1 Proteins 0.000 description 1
- 108090000189 Neuropeptides Proteins 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 241000606860 Pasteurella Species 0.000 description 1
- 241000606856 Pasteurella multocida Species 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 108010089814 Plant Lectins Proteins 0.000 description 1
- 102100029740 Poliovirus receptor Human genes 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 208000005342 Porcine Reproductive and Respiratory Syndrome Diseases 0.000 description 1
- 102000003923 Protein Kinase C Human genes 0.000 description 1
- 108090000315 Protein Kinase C Proteins 0.000 description 1
- 241000125945 Protoparvovirus Species 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 101000599859 Rattus norvegicus Intercellular adhesion molecule 1 Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 241000712907 Retroviridae Species 0.000 description 1
- 241000702670 Rotavirus Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241001138501 Salmonella enterica Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 108010047827 Sialic Acid Binding Immunoglobulin-like Lectins Proteins 0.000 description 1
- 102000007073 Sialic Acid Binding Immunoglobulin-like Lectins Human genes 0.000 description 1
- 101710150766 Sialic acid-binding lectin Proteins 0.000 description 1
- 101900350318 Simian immunodeficiency virus Surface protein gp120 Proteins 0.000 description 1
- 108020004459 Small interfering RNA Proteins 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000194021 Streptococcus suis Species 0.000 description 1
- 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 description 1
- 241000710924 Togaviridae Species 0.000 description 1
- 102100023935 Transmembrane glycoprotein NMB Human genes 0.000 description 1
- 241000711484 Transmissible gastroenteritis virus Species 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 102100028785 Tumor necrosis factor receptor superfamily member 14 Human genes 0.000 description 1
- 108091023045 Untranslated Region Proteins 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 108010048673 Vitronectin Receptors Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000004721 adaptive immunity Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000000961 alloantigen Effects 0.000 description 1
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000030741 antigen processing and presentation Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008436 biogenesis Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 238000012511 carbohydrate analysis Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 239000013553 cell monolayer Substances 0.000 description 1
- 230000008614 cellular interaction Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 229940031670 conjugate vaccine Drugs 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 210000001787 dendrite Anatomy 0.000 description 1
- 208000025729 dengue disease Diseases 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 210000003162 effector t lymphocyte Anatomy 0.000 description 1
- 230000026502 entry into host cell Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 208000012997 experimental autoimmune encephalomyelitis Diseases 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000009688 glial response Effects 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 230000005745 host immune response Effects 0.000 description 1
- 102000058166 human ICAM3 Human genes 0.000 description 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 229940127121 immunoconjugate Drugs 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 238000012744 immunostaining Methods 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000002608 insulinlike Effects 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- 210000003535 interstitial dendritic cell Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000001865 kupffer cell Anatomy 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000000670 ligand binding assay Methods 0.000 description 1
- 230000007762 localization of cell Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000005073 lymphatic endothelial cell Anatomy 0.000 description 1
- 210000003563 lymphoid tissue Anatomy 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000005541 medical transmission Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000002941 microtiter virus yield reduction assay Methods 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000007857 nested PCR Methods 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 108091027963 non-coding RNA Proteins 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229940051027 pasteurella multocida Drugs 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 102000013415 peroxidase activity proteins Human genes 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- PHEDXBVPIONUQT-RGYGYFBISA-N phorbol 13-acetate 12-myristate Chemical compound C([C@]1(O)C(=O)C(C)=C[C@H]1[C@@]1(O)[C@H](C)[C@H]2OC(=O)CCCCCCCCCCCCC)C(CO)=C[C@H]1[C@H]1[C@]2(OC(C)=O)C1(C)C PHEDXBVPIONUQT-RGYGYFBISA-N 0.000 description 1
- 239000002644 phorbol ester Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000003726 plant lectin Substances 0.000 description 1
- 108010048507 poliovirus receptor Proteins 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000004850 protein–protein interaction Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 208000017443 reproductive system disease Diseases 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000007423 screening assay Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000000225 synapse Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000010474 transient expression Effects 0.000 description 1
- 108091007466 transmembrane glycoproteins Proteins 0.000 description 1
- 102000027257 transmembrane receptors Human genes 0.000 description 1
- 108091008578 transmembrane receptors Proteins 0.000 description 1
- 230000014599 transmission of virus Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 230000007502 viral entry Effects 0.000 description 1
- 230000008478 viral entry into host cell Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000009447 viral pathogenesis Effects 0.000 description 1
- 229960004854 viral vaccine Drugs 0.000 description 1
- 230000024058 virion binding Effects 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/7056—Lectin superfamily, e.g. CD23, CD72
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80007P | 2007-10-29 | 2007-10-29 | |
| PCT/US2008/012251 WO2009058285A2 (en) | 2007-10-29 | 2008-10-29 | PORCINE DC-SIGN, ICAM-3 AND LSECtin AND USES THEREOF |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011501958A true JP2011501958A (ja) | 2011-01-20 |
| JP2011501958A5 JP2011501958A5 (https=) | 2011-12-15 |
Family
ID=40591693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010532042A Pending JP2011501958A (ja) | 2007-10-29 | 2008-10-29 | ブタＤＣ−ＳＩＧＮ、ＩＣＡＭ−３およびＬＳＥＣｔｉｎならびにそれらの使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8415118B2 (https=) |
| EP (2) | EP2662384A1 (https=) |
| JP (1) | JP2011501958A (https=) |
| KR (1) | KR20100087344A (https=) |
| CN (1) | CN102066415A (https=) |
| AU (1) | AU2008319384A1 (https=) |
| BR (1) | BRPI0818477A2 (https=) |
| CA (1) | CA2704207A1 (https=) |
| CO (1) | CO6270367A2 (https=) |
| MX (1) | MX2010004548A (https=) |
| NZ (1) | NZ584893A (https=) |
| RU (1) | RU2010121862A (https=) |
| WO (1) | WO2009058285A2 (https=) |
| ZA (1) | ZA201002773B (https=) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102947341B (zh) | 2010-01-19 | 2018-07-06 | 哈佛大学校长及研究员协会 | 用于病原体检测和治疗的工程化调理素 |
| WO2013012924A2 (en) | 2011-07-18 | 2013-01-24 | President And Fellows Of Harvard College | Engineered microbe-targeting molecules and uses thereof |
| WO2013090806A2 (en) | 2011-12-15 | 2013-06-20 | Washington University | Porcine knob xenotype chimeric adenoviral vector for dendritic cell infection |
| CN104284984B (zh) | 2012-02-29 | 2017-10-13 | 哈佛大学校长及研究员协会 | 抗生素药敏性的快速测试 |
| JP6254146B2 (ja) | 2012-03-27 | 2017-12-27 | エヌジーエム バイオファーマシューティカルス，インコーポレーテッド | 代謝障害を治療するための組成物および方法 |
| EP2976642A4 (en) | 2013-03-15 | 2016-09-21 | Harvard College | METHOD AND COMPOSITIONS FOR IMPROVING THE DETECTION AND / OR RECORDING OF A TARGET UNIT |
| WO2014190040A1 (en) | 2013-05-21 | 2014-11-27 | President And Fellows Of Harvard College | Engineered heme-binding compositions and uses thereof |
| EP3083658B1 (en) | 2013-12-18 | 2019-05-08 | President and Fellows of Harvard College | Crp capture/detection of gram positive bacteria |
| MX370115B (es) | 2014-07-30 | 2019-12-02 | Ngm Biopharmaceuticals Inc | Dímeros que comprenden dos polipéptidos, útiles en el tratamiento de trastornos metabólicos. |
| US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
| PL3212226T3 (pl) | 2014-10-31 | 2020-11-02 | Ngm Biopharmaceuticals, Inc. | Kompozycje i sposoby stosowania w leczeniu zaburzeń metabolicznych |
| CN104749361B (zh) * | 2015-01-21 | 2017-04-19 | 中国农业科学院哈尔滨兽医研究所 | 猪圆环病毒2型抗原捕获elisa试剂盒 |
| CN105445457B (zh) * | 2015-03-24 | 2017-08-11 | 中国农业科学院哈尔滨兽医研究所 | 检测猪圆环病毒2型Cap蛋白的单克隆抗体及试剂盒 |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US10435457B2 (en) | 2015-08-06 | 2019-10-08 | President And Fellows Of Harvard College | Microbe-binding molecules and uses thereof |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| CN106957847A (zh) * | 2017-05-16 | 2017-07-18 | 吉林大学 | 有效抑制仔猪流行性腹泻病毒的siRNA及用途 |
| CN107488635A (zh) * | 2017-09-22 | 2017-12-19 | 中国人民解放军第三军医大学第三附属医院 | 单克隆细胞及其制备方法和用途 |
| CN108893474B (zh) * | 2018-02-07 | 2021-11-16 | 电子科技大学 | 草鱼细胞间粘附分子基因的分离和鉴定 |
| CN108977444A (zh) * | 2018-06-28 | 2018-12-11 | 西南大学 | 沉默荣昌猪CD14表达的siRNA及筛选方法与应用 |
| CN109679952B (zh) * | 2018-12-24 | 2022-04-15 | 西北农林科技大学 | 一种抗PRRSV感染的猪源miR-c89及其应用 |
| CN109652384B (zh) * | 2019-02-21 | 2021-10-26 | 昆明理工大学 | 一种体外培养戊型肝炎病毒的方法 |
| CN109836478B (zh) * | 2019-03-19 | 2022-06-14 | 扬州大学 | 非洲猪瘟病毒p11.5蛋白特异性多克隆抗体的制备方法及应用 |
| CN109943536B (zh) * | 2019-03-26 | 2021-09-14 | 昆明理工大学 | 一种戊型肝炎病毒的培养方法及其灭活疫苗的制备方法 |
| CN111575409B (zh) * | 2020-05-23 | 2023-04-18 | 黑龙江八一农垦大学 | 基于整合素配体识别肽抑制猪流行性腹泻病毒感染的研究方法 |
| WO2022050476A1 (ko) * | 2020-09-04 | 2022-03-10 | 이형우 | 인간 면역결핍 바이러스 감염 또는 감염 질환의 치료용 조성물 |
| CN115725656B (zh) * | 2021-09-01 | 2026-01-16 | 联邦生物科技(珠海横琴)有限公司 | 一种以细胞质rna病毒为载体递送干扰rna的方法 |
| CN121454060A (zh) * | 2026-01-05 | 2026-02-03 | 江苏立维斯德生物技术有限公司 | 一种基于免疫荧光法检测轮状病毒的方法、试剂盒及其用途 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07509599A (ja) * | 1992-06-11 | 1995-10-26 | ニューヨーク ユニバーシティー | キメラ受容体ポリペプチド，ヒトｈ１３タンパク質，ならびにその使用 |
| JP2002543762A (ja) * | 1999-03-25 | 2002-12-24 | ブリストル−マイヤーズ スクイブ カンパニー | ヒトｃｌａｘタンパク質およびその可溶性融合タンパク質をコードするｄｎａ分子 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9409768D0 (en) | 1994-05-16 | 1994-07-06 | Medical Res Council | Trimerising polypeptides |
| US6146873A (en) | 1994-11-10 | 2000-11-14 | Baxter Aktiengesellschaft | Production of orthomyxoviruses in monkey kidney cells using protein-free media |
| US6280953B1 (en) | 1998-01-30 | 2001-08-28 | Evolutionary Genomics, L.L.C. | Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
| US6365156B1 (en) | 1999-04-16 | 2002-04-02 | Osel, Inc. | Method for improving the half-life of soluble viral-specific ligands on mucosal membranes |
| EP1046651A1 (en) | 1999-04-19 | 2000-10-25 | Koninklijke Universiteit Nijmegen | Composition and method for modulating dendritic cell-T interaction |
| US6391567B1 (en) | 2000-03-02 | 2002-05-21 | New York University | Identifying compounds inhibiting DC-sign facilitation of HIV into cells |
| GB0318247D0 (en) * | 2003-08-05 | 2003-09-10 | Royal Veterinary College | Antigen delivery system |
| BRPI0508762A (pt) | 2004-04-16 | 2007-08-14 | Genentech Inc | método de aumento do esgotamento de células b em mamìferos, método de aumento da eficácia do esgotamento de células b, método de tratamento de malignidade ou neoplasma de células b, método de alìvio de disfunção autoimunológica regulada por células b, método de esgotamento das células b e composição |
-
2008
- 2008-10-29 JP JP2010532042A patent/JP2011501958A/ja active Pending
- 2008-10-29 NZ NZ584893A patent/NZ584893A/xx not_active IP Right Cessation
- 2008-10-29 WO PCT/US2008/012251 patent/WO2009058285A2/en not_active Ceased
- 2008-10-29 BR BRPI0818477 patent/BRPI0818477A2/pt not_active IP Right Cessation
- 2008-10-29 CA CA2704207A patent/CA2704207A1/en not_active Abandoned
- 2008-10-29 RU RU2010121862/10A patent/RU2010121862A/ru not_active Application Discontinuation
- 2008-10-29 EP EP13179857.1A patent/EP2662384A1/en not_active Withdrawn
- 2008-10-29 US US12/739,744 patent/US8415118B2/en not_active Expired - Fee Related
- 2008-10-29 AU AU2008319384A patent/AU2008319384A1/en not_active Abandoned
- 2008-10-29 CN CN2008801240560A patent/CN102066415A/zh active Pending
- 2008-10-29 KR KR1020107011603A patent/KR20100087344A/ko not_active Withdrawn
- 2008-10-29 EP EP08844649A patent/EP2207798A2/en not_active Withdrawn
- 2008-10-29 MX MX2010004548A patent/MX2010004548A/es active IP Right Grant
-
2010
- 2010-04-20 ZA ZA2010/02773A patent/ZA201002773B/en unknown
- 2010-04-29 CO CO10050942A patent/CO6270367A2/es not_active Application Discontinuation
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07509599A (ja) * | 1992-06-11 | 1995-10-26 | ニューヨーク ユニバーシティー | キメラ受容体ポリペプチド，ヒトｈ１３タンパク質，ならびにその使用 |
| JP2002543762A (ja) * | 1999-03-25 | 2002-12-24 | ブリストル−マイヤーズ スクイブ カンパニー | ヒトｃｌａｘタンパク質およびその可溶性融合タンパク質をコードするｄｎａ分子 |
Non-Patent Citations (15)
| Title |
|---|
| JPN6013031838; ＨＵＡＮＧ， Ｙ．Ｗ． ｅｔ ａｌ．: Ｄｅｖ． Ｃｏｍｐ． Ｉｍｍｕｎｏｌ． , 20081023, ｐｐ．４６４-４８０ * |
| JPN6013031839; ＴＥＵＮＩＳ， Ｂ． ｅｔ ａｌ．: Ｊ． Ｂｉｏｌ． Ｃｈｅｍ． Ｖｏｌ．２７７, 2002, ｐｐ．１１３１４-１１３２０ * |
| JPN6013031840; ＬＥＥＢ， Ｔ． ａｎｄ ＭＵＬＬＥＲ， Ｍ．: Ｇｅｎｅ Ｖｏｌ．３４３, 2004, ｐｐ．２３９-２４４ * |
| JPN6013031841; ＰＡＲＫ， Ｃ．Ｇ． ｅｔ ａｌ．: Ｉｎｔ． Ｉｍｍｕｎｏｌ． Ｖｏｌ．１３， Ｎｏ．１０, 2001, ｐｐ．１２８３-１２９０ * |
| JPN6013031843; ＰＯＷＬＥＳＬＡＮＤ， Ａ．Ｓ． ｅｔ ａｌ．: Ｊ． Ｂｉｏｌ． Ｃｈｅｍ． Ｖｏｌ．２８３, 20071105, ｐｐ．５９３-６０２ * |
| JPN6013031845; ＬＯＶＩＮＧ， Ｃ．Ｌ． ｅｔ ａｌ．: Ｉｍｍｕｎｏｌｏｇｙ Ｖｏｌ．１２０, 2006, ｐｐ．２１７-２２９ * |
| JPN6013031847; ＢＯＷＤＥＮ， Ｔ．Ａ． ｅｔ ａｌ．: Ｊ． Ｖｉｒｏｌ． Ｖｏｌ．８２，Ｎｏ．２３, 20080924, ｐｐ．１１６２８-１１６３６ * |
| JPN6013031849; ＵＥＮＩＳＨＩ， Ｈ．: '"ＣＪ００７７７７ ｆｕｌｌ-ｌｅｎｇｔｈ ｅｎｒｉｃｈｅｄ ｓｗｉｎｅ ｃＤＮＡ ｌｉｂｒａｒｙ， ａｄｕｌｔ ｍｅｓｅｎｔｅｒｉｃ ｌｙｍｐｈ ｎｏｄｅ Ｓｕｓ ｓｃｒｏｆａ ｃＤＮＡ ｃｌｏｎｅ' ＧｅｎＢａｎｋ Ａｃｃｅｓｓｉｏｎ ｎｏ． ＣＪ００７７７７ * |
| JPN6013031851; ＬＥＥＢ， Ｔ．: '"Ｓｕｓ ｓｃｒｏｆａ ｐａｒｔｉａｌ ＩＣＡＭ３ ｇｅｎｅ， ＴＹＫ２， ＣＤＣ３７， ＰＤＥ４Ａ， ＫＥＡＰ１， ＥＤＧ８ ａｎｄ ＡＰＧ４Ｄ ｇｅｎｅｓ ａｎｄ ｐａｒｔｉａｌ ＦＬＪ１２９４９' ＧｅｎＢａｎｋ Ａｃｃｅｓｓｉｏｎ ｎｏ． ＡＪ６３２３０３ , 20061115 * |
| JPN6013031853; ＢＡＳＨＩＲＯＶＡ， Ａ．Ａ． ｅｔ ａｌ．: Ｊ． Ｖｉｒｏｌ． Ｖｏｌ．７７， Ｎｏ．１, 2003, ｐｐ．２１７-２２７ * |
| JPN6013031855; ＢＡＲＩＢＡＵＤ， Ｆ． ｅｔ ａｌ．: Ｊ． Ｖｉｒｏｌ． Ｖｏｌ．７５， Ｎｏ．２１, 2001, ｐｐ．１０２８１-１０２８９ * |
| JPN6013031857; ＬＩＵ， Ｗ． ｅｔ ａｌ．: Ｊ． Ｂｉｏｌ． Ｃｈｅｍ． Ｖｏｌ．２７９， Ｎｏ．１８, 2004, ｐｐ．１８７４８-１８７５８ * |
| JPN6013031859; ＰＡＩＬＬＯＴ， Ｒ． ｅｔ ａｌ．: Ｉｍｍｕｎｏｌｏｇｙ Ｖｏｌ．１０２, 2001, ｐｐ．３９６-４０４ * |
| JPN6013031860; ＲＥＥＶＥＳ， Ｊ．Ｄ． ｅｔ ａｌ．: Ｊ． Ｇｅｎ． Ｖｉｒｏｌ． Ｖｏｌ．７９, 1998, ｐｐ．１７９３-１７９９ * |
| JPN6013031862; ＫＡＲＬＳＳＯＮ， Ｉ． ｅｔ ａｌ．: ＡＩＤＳ Ｖｏｌ．１７, 2003, ｐｐ．２５６１-２５６９ * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009058285A9 (en) | 2009-07-09 |
| NZ584893A (en) | 2012-08-31 |
| US8415118B2 (en) | 2013-04-09 |
| US20100317054A1 (en) | 2010-12-16 |
| KR20100087344A (ko) | 2010-08-04 |
| CO6270367A2 (es) | 2011-04-20 |
| ZA201002773B (en) | 2011-10-26 |
| EP2207798A2 (en) | 2010-07-21 |
| WO2009058285A2 (en) | 2009-05-07 |
| CA2704207A1 (en) | 2009-05-07 |
| EP2662384A1 (en) | 2013-11-13 |
| WO2009058285A3 (en) | 2009-12-10 |
| RU2010121862A (ru) | 2011-12-10 |
| AU2008319384A1 (en) | 2009-05-07 |
| CN102066415A (zh) | 2011-05-18 |
| MX2010004548A (es) | 2010-05-05 |
| BRPI0818477A2 (pt) | 2015-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8415118B2 (en) | Porcine DC-SIGN, ICAM-3 and LSECtin and uses thereof | |
| Huang et al. | Porcine DC-SIGN: molecular cloning, gene structure, tissue distribution and binding characteristics | |
| EP3311832A1 (en) | Chimeric antigen receptor specific for tumor cells | |
| CN115916833B (zh) | 靶向b7h3的抗原结合多肽及其应用 | |
| JP2011206060A (ja) | 可変性リンパ球受容体、その関連ポリペプチドおよび核酸、ならびにその使用 | |
| BR112019017008A2 (pt) | anticorpo, ácido nucleico, vetor de expressão, célula hospedeira, imunoconjugado multifuncional, receptor de antígeno quimérico, vírus, célula imune modificada pelo receptor do antígeno quimérico, composição farmacêutica, kit, e, uso do anticorpo. | |
| TW202342550A (zh) | 靶向ｂｃｍａ和ｇｐｒｃ５ｄ的嵌合抗原受體及其應用 | |
| US20230210902A1 (en) | Sars-cov-2-specific t cells | |
| WO2023274385A1 (zh) | 靶向her2的通用型car-t细胞及其制备方法 | |
| WO2024094165A1 (zh) | 靶向b7h3的通用型car-t细胞及其制备方法和应用 | |
| IL294960A (en) | Delivery of sialidase to cancer cells, immune cells and the tumor microenvironment | |
| NO341211B1 (no) | In vitro fremgangsmåte for å fremme infeksjon i en virveldyrcelle med PRRSV og en fremgangsmåte for å måle tilbøyeligheten en testcellelinje har for å tillate PRRSV-infeksjon | |
| CN118056008A (zh) | 病毒载体生产系统 | |
| AU2013204023A1 (en) | PORCINE DC-SIGN, ICAM AND LSECtin AND USES THEREOF | |
| WO2021232050A1 (en) | Natural killer cell immunotherapy for the treatment or prevention of sars-cov-2 infection | |
| AU2020391178A1 (en) | Immune cell delivery of sialidase to cancer cells, immune cells and the tumor microenvironment | |
| CN120112650A (zh) | 慢病毒配制品 | |
| JP2024527537A (ja) | Ｇｄ２を標的とするユニバーサルｃａｒ－ｔ細胞及びその製造方法並びに使用 | |
| JP2024527539A (ja) | ＩＬ１３Ｒα２を標的としたユニバーサルＣＡＲ－Ｔ細胞及びその製造方法と使用 | |
| JP2025525439A (ja) | 操作されたナチュラルキラー（ｎｋ）細胞と抗体療法との組み合わせおよび関連する方法 | |
| WO2023274386A1 (zh) | 靶向egfr的通用型car-t细胞及其制备方法 | |
| HK1157797A (en) | Porcine dc-sign, icam-3 and lsectin and uses thereof | |
| KR20250054790A (ko) | 키메라 항원 수용체 도메인 | |
| HK40087387A (zh) | 靶向b7h3的抗原结合多肽及其应用 | |
| HK40087387B (zh) | 靶向b7h3的抗原结合多肽及其应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111027 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20111027 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130702 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20131126 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20140120 |